Treating foot infections in diabetic patients: A randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate

John G. Bartlett

doi:10.1097/01.idc.0000130890.12611.f3

Treating foot infections in diabetic patients: A randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate

John G. Bartlett

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	267-268
Number of pages	2
Journal	Infectious Diseases in Clinical Practice
Volume	12
Issue number	4
DOIs	https://doi.org/10.1097/01.idc.0000130890.12611.f3
State	Published - 2004
Externally published	Yes

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1097/01.idc.0000130890.12611.f3

Cite this

@article{486b1a37cbb04b85bb30aa0f273ac67c,

title = "Treating foot infections in diabetic patients: A randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate",

author = "Bartlett, {John G.}",

year = "2004",

doi = "10.1097/01.idc.0000130890.12611.f3",

language = "English (US)",

volume = "12",

pages = "267--268",

journal = "Infectious Diseases in Clinical Practice",

issn = "1056-9103",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - Treating foot infections in diabetic patients

T2 - A randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate

AU - Bartlett, John G.

PY - 2004

Y1 - 2004

UR - http://www.scopus.com/inward/record.url?scp=85026140558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026140558&partnerID=8YFLogxK

U2 - 10.1097/01.idc.0000130890.12611.f3

DO - 10.1097/01.idc.0000130890.12611.f3

M3 - Article

AN - SCOPUS:85026140558

SN - 1056-9103

VL - 12

SP - 267

EP - 268

JO - Infectious Diseases in Clinical Practice

JF - Infectious Diseases in Clinical Practice

IS - 4

ER -

Treating foot infections in diabetic patients: A randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this